• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Chemical Profile of 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- (CAS No. 89106-46-7)

1-Propanone, 1-(2-fluoro-5-methoxyphenyl)-, identified by its Chemical Abstracts Service (CAS) number 89106-46-7, is a fluorinated aromatic ketone that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its structural motif of a fluoro-substituted phenyl ring linked to a propanone backbone, exhibits unique chemical and biological properties that make it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The molecular structure of 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- consists of a central propanone group (acetone derivative) with an aromatic ring substituted at the 2-position with a fluorine atom and at the 5-position with a methoxy group. This specific arrangement imparts both electronic and steric effects that influence its reactivity and interaction with biological targets. The presence of the fluorine atom enhances lipophilicity and metabolic stability, while the methoxy group contributes to hydrogen bonding capabilities, making this compound a versatile scaffold for drug design.

In recent years, the pharmaceutical industry has increasingly focused on fluorinated compounds due to their improved pharmacokinetic profiles. The incorporation of fluorine into drug molecules often leads to enhanced binding affinity, reduced metabolic clearance, and increased resistance to enzymatic degradation. Research has demonstrated that fluorine atoms can modulate the electronic properties of aromatic rings, influencing both the potency and selectivity of bioactive compounds. The compound 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)-, with its dual substitution pattern, exemplifies how strategic fluorination can be leveraged to optimize drug-like properties.

One of the most compelling applications of this compound lies in its role as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play critical roles in cell signaling pathways and are frequently targeted in oncology and inflammatory diseases. The structural features of 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- make it an ideal building block for designing inhibitors that bind to the ATP-binding pockets of kinases. Studies have shown that fluorinated aromatic ketones can act as scaffolds for developing small-molecule inhibitors with high affinity and selectivity. For instance, derivatives of this compound have been investigated for their potential in inhibiting tyrosine kinases, which are overexpressed in many cancer cell lines.

Furthermore, the compound has shown promise in the development of central nervous system (CNS) therapeutics. The combination of lipophilicity imparted by the fluoro-substituent and hydrogen bonding capabilities provided by the methoxy group allows for efficient blood-brain barrier penetration. This makes 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- a suitable candidate for synthesizing neuroactive compounds targeting disorders such as Alzheimer's disease, Parkinson's disease, and depression. Recent research has highlighted its utility in generating novel ligands for serotonin receptors, which are implicated in mood regulation and cognitive function.

The synthesis of 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- typically involves multi-step organic reactions starting from commercially available precursors like fluoroaryl aldehydes or ketones. The introduction of the methoxy group is commonly achieved through nucleophilic aromatic substitution (SNAr), while the attachment to the propanone backbone can be accomplished via condensation reactions or palladium-catalyzed cross-coupling processes. Advanced synthetic methodologies have been employed to improve yield and purity, ensuring that pharmaceutical-grade material is obtained for further development.

In terms of biological activity, preliminary studies on derivatives of 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- have revealed interesting pharmacological profiles. Some analogs have demonstrated inhibitory effects against bacterial enzymes involved in DNA gyrase inhibition, suggesting potential applications in antibiotic development. Additionally, modifications to the aromatic ring have led to compounds with anti-inflammatory properties by targeting cyclooxygenase (COX) enzymes. These findings underscore the versatility of this scaffold and its potential utility across multiple therapeutic areas.

The growing interest in fluorinated heterocycles has also spurred innovation in synthetic chemistry. Researchers have developed novel catalytic systems that enable efficient fluorination reactions under mild conditions, reducing unwanted side products and improving overall sustainability. Techniques such as transition-metal-catalyzed C-F bond formation have been particularly useful in introducing fluorine atoms into complex molecular frameworks while maintaining high regioselectivity. This progress has made it feasible to explore more intricate derivatives of 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)-, expanding its potential applications.

Looking ahead, the future direction of research involving 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- is likely to focus on expanding its therapeutic applications through structure-activity relationship (SAR) studies. By systematically modifying various functional groups on the aromatic ring or exploring different substituents on the propanone moiety, scientists aim to identify compounds with enhanced potency and reduced toxicity. Computational modeling techniques will also play a crucial role in predicting biological activity and optimizing molecular design before experimental validation.

The integration of machine learning algorithms into drug discovery pipelines has accelerated the identification of promising candidates like those derived from 1-Propanone, 1-(2-fluoro-5-methoxyphenyl)-. These tools can analyze vast datasets to identify patterns that correlate structural features with biological outcomes, enabling more targeted experimentation. As computational power increases and datasets grow larger, AI-driven approaches will become increasingly indispensable in optimizing lead compounds for clinical development.

In conclusion,1-Propanone, 1-(2-fluoro-5-methoxyphenyl)- (CAS No. 89106-46-7) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and versatile reactivity. Its role as an intermediate in synthesizing kinase inhibitors and CNS therapeutics highlights its importance in addressing critical unmet medical needs. With ongoing innovations in synthetic methodologies and computational drug design, this compound is poised to remain at the forefront of medicinal chemistry research for years to come.

• 66938-29-2(2-Fluoro-4'-methoxybenzophenone)
• 74457-86-6(1-(2-fluoro-4-methoxyphenyl)ethan-1-one)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)